All Stories

  1. STABIL-study: The Course of Therapy, Safety and Pharmacokinetic Parameters of Conversion of Prograf® to Tacrolimus HEXAL®/Crilomus® in Renal Transplant Recipients – An Observational Study in Germany

    Article • Current Reviews in Clinical and Experimental Pharmacology, November 2021, Bentham Science Publishers

    Klemens Budde, Kerstin Dienes

  2. Conversion from Calcineurin Inhibitor– to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial

    Article • Journal of the American Society of Nephrology, October 2021, American Society of Nephrology

    Klemens Budde

  3. Any Progress in the Treatment of Antibody-Mediated Rejection?

    Article • Journal of the American Society of Nephrology, January 2018, American Society of Nephrology

    Klemens Budde

  4. Clinical and Molecular Characterization of Patients with Heterozygous Mutations in Wilms Tumor Suppressor Gene 1

    Article • Clinical Journal of the American Society of Nephrology, March 2015, American Society of Nephrology

    Dr. Uwe Querfeld, Klemens Budde

  5. Bortezomib-Based Antibody Reduction Therapy: The First Step to “True” Desensitization?

    Article • American Journal of Transplantation, December 2014, Wiley

    Klemens Budde

  6. Five-Year Outcomes in Kidney Transplant Patients Converted From Cyclosporine to Everolimus: The Randomized ZEUS Study

    Article • American Journal of Transplantation, December 2014, Wiley

    Klemens Budde